AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2449724 — intervention group
Group type: EXPERIMENTAL
Intervention: Both surgical procedures (TURP and TUI)
Number of subjects: 21
Study 30729863 — intervention group
Group type: EXPERIMENTAL
Intervention: Agentic narcissism
Number of subjects: 474
Study 30729863 — intervention group
Group type: EXPERIMENTAL
Intervention: Communal narcissism
Number of subjects: 474
Study 30729863 — intervention group
Group type: COMPARATOR
Intervention: Non-narcissists
Number of subjects: 474
Study 29178564 — intervention group
Group type: EXPERIMENTAL
Intervention: UC-MSC infusion (1 × 10^6 /kg body weight)
Number of subjects: 27
Study 29178564 — intervention group
Group type: EXPERIMENTAL
Intervention: UC-MSC infusion
Number of subjects: 27
Study 29178564 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study 25381588 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-site laparoscopic surgery (SSLS) using conventional laparoscopic (CL) instruments
Number of subjects: 60
Study 25381588 — intervention group
Group type: COMPARATOR
Intervention: 3-port conventional laparoscopic (CL) appendectomy
Number of subjects: 60
Study 23820246 — intervention group
Group type: EXPERIMENTAL
Intervention: LP299v
Number of subjects: 25
Study 23820246 — intervention group
Group type: COMPARATOR
Intervention: Placebo (inactivated LP299v)
Number of subjects: 25
Study 23820246 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 25
Study 20406393 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 283
Study 20406393 — intervention group
Group type: EXPERIMENTAL
Intervention: Nystatin
Number of subjects: 283
Study 20406393 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole (susceptible isolates)
Number of subjects: 283
Study 20406393 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole (SDD isolates)
Number of subjects: 283
Study 20406393 — intervention group
Group type: COMPARATOR
Intervention: Candida albicans and non-albicans Candida species
Number of subjects: 283
Study 19841335 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day course of amoxicillin
Number of subjects: 49
Study 19841335 — intervention group
Group type: COMPARATOR
Intervention: 7-day course of amoxicillin
Number of subjects: 49
Study 16962481 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthetic with EMLA (eutectic mixture of lidocaine and prilocaine)
Number of subjects: 225
Study 16962481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225
Study 15513256 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiplication facts retrieval in a number-matching task without arithmetic context.
Number of subjects: 0
Study 15513256 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of spatial relation between cue digits.
Number of subjects: 0
Study 15513256 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextual definition of automaticity applied to multiplication facts retrieval.
Number of subjects: 0
Study 11345650 — intervention group
Group type: EXPERIMENTAL
Intervention: Amsalog 200 mg/m2 per day for 5 days
Number of subjects: 19
Study 11345650 — intervention group
Group type: EXPERIMENTAL
Intervention: Amsalog 180 mg/m2 per day for 5 days
Number of subjects: 19
Study 11345650 — intervention group
Group type: EXPERIMENTAL
Intervention: Amsalog administered via peripheral venous line
Number of subjects: 19
Study 11345650 — intervention group
Group type: EXPERIMENTAL
Intervention: Amsalog
Number of subjects: 19
Study 11345650 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacokinetic studies
Number of subjects: 19
Study 9574945 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate mouthrinse
Number of subjects: 279
Study 9574945 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthrinse
Number of subjects: 279
Study 9574945 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (in female subjects)
Number of subjects: 279
Study 9574945 — intervention group
Group type: COMPARATOR
Intervention: Nonuse of oral contraceptives (in female subjects)
Number of subjects: 279
Study 9574945 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 279
Study 7826781 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopentone
Number of subjects: 0
Study 7826781 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0
Study 3254133 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG monitoring during carotid endarterectomy
Number of subjects: 131
Study 3254133 — intervention group
Group type: COMPARATOR
Intervention: No EEG monitoring during carotid endarterectomy
Number of subjects: 131
Study 3254133 — intervention group
Group type: EXPERIMENTAL
Intervention: No shunting with ICBP < 50 mmHg and no EEG change
Number of subjects: 131
Study 3254133 — intervention group
Group type: EXPERIMENTAL
Intervention: Low ICBP with EEG change
Number of subjects: 131
Study 3254133 — intervention group
Group type: EXPERIMENTAL
Intervention: Low ICBP without EEG change
Number of subjects: 131
Study 29788981 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib 800 mg once daily
Number of subjects: 1066
Study 29788981 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib 50 mg once daily (in 6-week cycles: 4 weeks on, 2 weeks off)
Number of subjects: 1066
Study 29231405 — intervention group
Group type: EXPERIMENTAL
Intervention: Herb-partition moxibustion and acupuncture
Number of subjects: 102
Study 29231405 — intervention group
Group type: COMPARATOR
Intervention: Bran-partition moxibustion and shallow acupuncture
Number of subjects: 102
Study 24785592 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on Task 1 (red/green signal discrimination)
Number of subjects: 0
Study 24785592 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion modeling analysis
Number of subjects: 0
Study 23942259 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 125
Study 23942259 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 125
Study 20129336 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-generation thermal uterine balloon therapy system with postprocedure curettage
Number of subjects: 250
Study 20129336 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-generation thermal uterine balloon therapy system without postprocedure curettage
Number of subjects: 250
Study 20129336 — intervention group
Group type: COMPARATOR
Intervention: First-generation thermal uterine balloon therapy system (historic control)
Number of subjects: 250
Study 20129336 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-generation thermal uterine balloon therapy system (compared to first-generation)
Number of subjects: 250
Study 18438129 — intervention group
Group type: EXPERIMENTAL
Intervention: Ophthalmology - Retinal reattachment surgery
Number of subjects: 921
Study 18438129 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthopaedics - Total hip replacement
Number of subjects: 921
Study 18438129 — intervention group
Group type: EXPERIMENTAL
Intervention: General Surgery - Hernia repair
Number of subjects: 921
Study 16619231 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower dose: 1.1 x 10(11) platelets/m(2)
Number of subjects: 1350
Study 16619231 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium dose: 2.2 x 10(11) platelets/m(2)
Number of subjects: 1350
Study 16619231 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose: 4.4 x 10(11) platelets/m(2)
Number of subjects: 1350
Study 12047429 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic group (dust mite impermeable mattress covers and advice on environmental measures)
Number of subjects: 242
Study 12047429 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-specific advice)
Number of subjects: 242
Study 9672054 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (mean daily dose 2.9 mg, SD 1.4)
Number of subjects: 31
Study 9672054 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 31
Study 9672054 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label risperidone
Number of subjects: 31
Study 8006274 — intervention group
Group type: EXPERIMENTAL
Intervention: Active nitroglycerin patch therapy (0.4 mg/h, 12 h on/off)
Number of subjects: 40
Study 8006274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 2690923 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP (COP + doxorubicin)
Number of subjects: 70
Study 2690923 — intervention group
Group type: COMPARATOR
Intervention: COP
Number of subjects: 70
Study 134670 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 83
Study 134670 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 30227731 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 110
Study 30227731 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 110
Study 30720543 — intervention group
Group type: EXPERIMENTAL
Intervention: Single exposure to general anesthesia lasting less than 1 hour
Number of subjects: 0
Study 30720543 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple exposures to general anesthesia
Number of subjects: 0
Study 28368340 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat breakfast
Number of subjects: 30
Study 28368340 — intervention group
Group type: COMPARATOR
Intervention: Low-fat breakfast
Number of subjects: 30
Study 24219251 — intervention group
Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope
Number of subjects: 70
Study 24219251 — intervention group
Group type: COMPARATOR
Intervention: GlideScope
Number of subjects: 70
Study 21895949 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure
Number of subjects: 140
Study 21895949 — intervention group
Group type: COMPARATOR
Intervention: Conventional bipolar instruments
Number of subjects: 140
Study 19294323 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate advice (intervention group)
Number of subjects: 344
Study 19294323 — intervention group
Group type: COMPARATOR
Intervention: Advice after 6 months (control group)
Number of subjects: 344
Study 16781793 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (30 mg)
Number of subjects: 18
Study 15856859 — intervention group
Group type: EXPERIMENTAL
Intervention: Manidipine
Number of subjects: 53
Study 15856859 — intervention group
Group type: EXPERIMENTAL
Intervention: Lercanidipine
Number of subjects: 53
Study 15856859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 11553256 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 2 microg kg(‐1) followed by 0.4 microg kg(‐1) min(‐1)
Number of subjects: 286
Study 11553256 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 1 microg kg(‐1) followed by 0.2 microg kg(‐1) min(‐1)
Number of subjects: 286
Study 11553256 — intervention group
Group type: EXPERIMENTAL
Intervention: Both remifentanil groups
Number of subjects: 286
Study 11553256 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil infusion at 0.1 microg kg(‐1) min(‐1)
Number of subjects: 286
Study 11553256 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl 3 microg kg(‐1)
Number of subjects: 286
Study 9732187 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release (SR) alfuzosin (5 mg twice daily)
Number of subjects: 1051
Study 9732187 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of SR alfuzosin and finasteride (5 mg once daily)
Number of subjects: 1051
Study 9732187 — intervention group
Group type: COMPARATOR
Intervention: Finasteride (5 mg once daily)
Number of subjects: 1051
Study 8299319 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 micrograms clonidine per day
Number of subjects: 0
Study 8299319 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 micrograms clonidine per day
Number of subjects: 0
Study 8299319 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms clonidine per day
Number of subjects: 0
Study 8299319 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2191978 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (25 mg)
Number of subjects: 8
Study 2191978 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide (20 mg) with captopril
Number of subjects: 8
Study 2191978 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (20 mg) alone
Number of subjects: 8
Study 1093503 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide for six months
Number of subjects: 19
Study 1093503 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose cyclophosphamide plus prednisone for six months
Number of subjects: 19
Study 1093503 — intervention group
Group type: COMPARATOR
Intervention: Prednisone plus placebo for six months
Number of subjects: 19
Study 31248392 — intervention group
Group type: EXPERIMENTAL
Intervention: IMPower (girls' intervention)
Number of subjects: 0
Study 31248392 — intervention group
Group type: EXPERIMENTAL
Intervention: Source of Strength (boys' intervention)
Number of subjects: 0
Study 31248392 — intervention group
Group type: COMPARATOR
Intervention: Life skills standard of care intervention
Number of subjects: 0
Study 31248392 — intervention group
Group type: EXPERIMENTAL
Intervention: IMPower and Source of Strength interventions
Number of subjects: 0
Study 28724883 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (1000 mg) 3 times a day for 3 days
Number of subjects: 40
Study 28724883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 25464934 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 58
Study 25464934 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied Relaxation
Number of subjects: 58
Study 25464934 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination Treatment (for non-remitted patients)
Number of subjects: 58
Study 25464934 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Treatments
Number of subjects: 58
Study 23768206 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS)
Number of subjects: 0
Study 23768206 — intervention group
Group type: COMPARATOR
Intervention: Control group (children whose asthma is controlled by ICS)
Number of subjects: 0
Study 21665167 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee Injury and Osteoarthritis Outcome Score (KOOS)
Number of subjects: 39
Study 21665167 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-minute walk (6MW)
Number of subjects: 39
Study 21665167 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed-up-and-go (TUG)
Number of subjects: 39
Study 21665167 — intervention group
Group type: EXPERIMENTAL
Intervention: Stair climbing tests (SCT)
Number of subjects: 39
Study 21665167 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadriceps strength
Number of subjects: 39
Study 20183467 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted maximum likelihood methodology
Number of subjects: 0
Study 20183467 — intervention group
Group type: EXPERIMENTAL
Intervention: Substitution‐based approach
Number of subjects: 0
Study 20183467 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct targeting of the logrank parameter
Number of subjects: 0
Study 16669830 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency physicians' ECG interpretation
Number of subjects: 133
Study 16669830 — intervention group
Group type: EXPERIMENTAL
Intervention: Likelihood classification by emergency physicians
Number of subjects: 133
Study 16642612 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding therapy at Dachangshu (BL 25), Zusanli (ST 36), Shangjuxu (ST 37)
Number of subjects: 116
Study 16642612 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of salicylazosulfapyridine, 4-6 g/day
Number of subjects: 116
Study 14658949 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone 6 mg/day
Number of subjects: 49
Study 14658949 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 10073740 — intervention group
Group type: EXPERIMENTAL
Intervention: GI198745 (dutasteride) 0.01 to 40 mg single oral doses
Number of subjects: 32
Study 10073740 — intervention group
Group type: EXPERIMENTAL
Intervention: GI198745 (dutasteride) 0.1 mg daily doses
Number of subjects: 32
Study 10073740 — intervention group
Group type: EXPERIMENTAL
Intervention: GI198745 (dutasteride) above 1 mg daily doses
Number of subjects: 32
Study 7589382 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg rhDNase twice daily for 14 days
Number of subjects: 70
Study 7589382 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg rhDNase twice daily during the OEP
Number of subjects: 70
Study 7589382 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 14 days
Number of subjects: 70
Study 2187377 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with ketamine sedation (group 2 A)
Number of subjects: 36
Study 2187377 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia without ketamine sedation (group 2 B)
Number of subjects: 36
Study 2187377 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 36
Study 389103 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (200 mg capsules, Elixophyllin)
Number of subjects: 12
Study 389103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 389103 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 12
Study 31506739 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care
Number of subjects: 1012
Study 31506739 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1012
Study 27792020 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting boxing program + conventional physical therapy (3 times/week for 6 weeks)
Number of subjects: 26
Study 27792020 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (3 times/week for 6 weeks)
Number of subjects: 26
Study 25735561 — intervention group
Group type: EXPERIMENTAL
Intervention: Organised collagen in tumor-associated stroma
Number of subjects: 0
Study 25735561 — intervention group
Group type: EXPERIMENTAL
Intervention: Stromal organization
Number of subjects: 0
Study 25735561 — intervention group
Group type: EXPERIMENTAL
Intervention: Stromal organization determined on H&E-stained and AZAN-stained tissue sections
Number of subjects: 0
Study 23897229 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin ointment
Number of subjects: 203
Study 23897229 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin cream
Number of subjects: 203
Study 21672346 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-contrast CT arthrography
Number of subjects: 125
Study 21672346 — intervention group
Group type: COMPARATOR
Intervention: Conservative management (with physical rehabilitation) or standard surgery
Number of subjects: 125
Study 19835717 — intervention group
Group type: EXPERIMENTAL
Intervention: E2V/DNG
Number of subjects: 798
Study 19835717 — intervention group
Group type: COMPARATOR
Intervention: EE/LNG
Number of subjects: 798
Study 16982546 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) with a central dose of 15 Gy x 3 within 5-8 days
Number of subjects: 64
Study 16982546 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT)
Number of subjects: 64
Study 15249794 — intervention group
Group type: COMPARATOR
Intervention: Established group (weight loss, increased physical activity, reduced sodium and alcohol intake)
Number of subjects: 810
Study 15249794 — intervention group
Group type: COMPARATOR
Intervention: Established plus DASH diet group (established interventions plus DASH dietary pattern)
Number of subjects: 810
Study 15249794 — intervention group
Group type: COMPARATOR
Intervention: Advice-only group
Number of subjects: 810
Study 10884441 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 47
Study 10884441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 9065178 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior pubourethral ligament plication
Number of subjects: 109
Study 9065178 — intervention group
Group type: EXPERIMENTAL
Intervention: Pereyra suspension
Number of subjects: 109
Study 8376720 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocutech VES (experimental device)
Number of subjects: 56
Study 8376720 — intervention group
Group type: COMPARATOR
Intervention: DFV Expanded Field or Walter's Keplarian Close‐focus Telescope (control)
Number of subjects: 56
Study 3533421 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteinizing hormone releasing hormone (LHRH) injection
Number of subjects: 0
Study 3533421 — intervention group
Group type: COMPARATOR
Intervention: Testosterone injection
Number of subjects: 0
Study 3533421 — intervention group
Group type: COMPARATOR
Intervention: Hormonal fluctuations of the menstrual cycle in women
Number of subjects: 0
Study 31650314 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm local anesthetic (37 °C)
Number of subjects: 100
Study 31650314 — intervention group
Group type: COMPARATOR
Intervention: Room temperature local anesthetic (21 °C)
Number of subjects: 100
Study 31140759 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight stigma experienced by parents
Number of subjects: 453
Study 28645985 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised web-delivered cognitive behavioural intervention (CancerCope)
Number of subjects: 163
Study 28645985 — intervention group
Group type: COMPARATOR
Intervention: Static patient education website
Number of subjects: 163
Study 25487220 — intervention group
Group type: EXPERIMENTAL
Intervention: Program SI! intervention for cardiovascular health promotion
Number of subjects: 2011
Study 25487220 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI) classification
Number of subjects: 2011
Study 25487220 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex- and age-specific criteria for obesity
Number of subjects: 2011
Study 23329167 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer Agent
Number of subjects: 15
Study 21219106 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ml of 2% lidocaine
Number of subjects: 104
Study 21219106 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 104
Study 18845585 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based program for working parents
Number of subjects: 99
Study 18845585 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 99